SCHEMBL7952083

SCHEMBL7952083

CCCCCCC(C(=O)NO)S(=O)(=O)c1ccc(C(C(N)=O)C(=O)O)cc1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 10/20 0.65
MMP13 P45452 8/20 0.65
MMP9 P14780 7/20 0.65
ADAM17 P78536 3/20 0.65
MMP2 P08253 7/20 0.43
MMP3 P08254 5/20 0.43
MMP7 P09237 3/20 0.40
MMP12 P39900 3/20 0.40
ACE P12821 2/20 0.40
HDAC8 Q9BY41 4/20 0.38
HDAC3 O15379 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
NR1I2 O75469 1/20 0.38
PDE4A P27815 2/20 0.38
PDE4B Q07343 2/20 0.38
PDE4C Q08493 2/20 0.38
PDE4D Q08499 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27512626 0.82 MMP13 (0.75) MMP1MMP13MMP9ADAM17MMP2
SCHEMBL6927179 0.79 MMP1 (1.00) MMP1MMP13MMP9ADAM17MMP2
SCHEMBL6930723 0.79 MMP13 (0.82) MMP1MMP13MMP9ADAM17MMP2
SCHEMBL1847769 0.79 MMP1 (1.00) MMP1MMP13MMP9ADAM17MMP2
SCHEMBL6930804 0.78 MMP9 (0.66) MMP1MMP13MMP9ADAM17MMP2
SCHEMBL6928902 0.78 MMP9 (0.69) MMP1MMP13MMP9ADAM17MMP2
SCHEMBL7324090 0.78 MMP13 (0.71) MMP1MMP13MMP9ADAM17MMP2
SCHEMBL6929907 0.76 MMP1 (0.77) MMP1MMP13MMP9ADAM17MMP2
SCHEMBL6932375 0.76 MMP9 (0.73) MMP1MMP13MMP9ADAM17MMP2
SCHEMBL6935166 0.76 MMP1 (0.66) MMP1MMP13MMP9ADAM17MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6331563-B1 LOW MOLECULAR WEIGHT, NON-PEPTIDE INHIBITORS OF MATRIX METALLOPROTEINASES AND TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME; TREATING ARTHRITIS, TUMOR METASTASIS, ABNORMAL WOUND HEALING, PERIODONTAL DISEASE, BONE DISEASE, INSULIN RESISTANCE WYETH HOLDINGS CORPORATION 2001-12-18 US disclosed